Lifecare receives ethics approval for implantable diabetes sensor trial

Lifecare ASA has secured ethics approval from REK in Norway for its first-in-human trial of an implantable continuous glucose monitoring sensor for type 1 diabetes.

The trial will assess safety, tolerability, and accuracy of the wireless glucose sensor and awaits final regulatory clearance from the Norwegian Medicines Agency before commencing.